Deutsche Bank Says Pfizer (PFE) and Allergan (AGN) Deal Would Enhance Cash Access
Tweet Send to a Friend
Deutsche Bank maintained a Buy rating on Pfizer (NYSE: PFE) with a price target of $43. Comments follow rumors related ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
